Mozambique

in page functions
[French]
Mozambique
Total population (2018) 30,338,918
Birth cohort (2018) 1,141,595
Surviving Infants (surviving to 1 year per year, 2018) 1,077,629
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 57/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 79/1000
World Bank Index, IDA (2015) 3.48
Gross Nation Income (per capita US$, 2015) 590
Co-financing group (2018) Initial self-financing
No. of districts/territories (2017) 161

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Mozambique

Type of support

Approvals

2001-2022 (US$)
(20 Jul 2018)

Commitments

2001-2022 (US$)
(20 Jul 2018)

Disbursements

2000-2018 (US$)
(20 Jul 2018)

% Disbursed

(20 Jul 2018)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Total $214,684,132 $243,265,886 $225,159,847
Cash Support (CASHSUPP) $170,000 $170,000 $170,000 100%
Health system strengthening (HSS 1) $16,954,633 $26,531,387 $10,837,667 64%
HPV Demo (NVS) $56,503 $56,503 $56,503 100%
Immunisation services support (ISS) $1,665,500 $1,665,500 $1,665,500 100%
Injection Safety Devices (NVS) $1,449,969 $1,862,469 $1,569,377 108%
Injection safety support (INS) $835,881 $835,881 $835,881 100%
IPV (NVS) $7,367,626 $7,367,626 $4,879,567 66%
Measles (NVS) $1,077,756 $1,077,756 $1,077,756 100%
MR 1st dose (NVS) $721,500 $1,325,500 $731,016 101%
MR-Catch-up campaign (NVS) $9,499,000 $9,499,000 $9,743,546 103%
MR-Catch-up campaign op.costs (OPC) $7,935,500 $7,935,500 $7,879,866 99%
Penta (NVS) $45,679,360 $47,631,360 $45,877,693 100%
Pneumo (NVS) $83,576,911 $95,242,411 $101,403,544 121%
Product Switch Grant (PSG) $292,000 $292,000 $271,286 93%
Rotavirus (NVS) $15,795,174 $20,166,174 $16,553,826 105%
Tetra DTP-HepB (NVS) $16,897,320 $16,897,320 $16,897,320 100%
Vaccine Introduction Grant (VIG) $4,709,499 $4,709,499 $4,709,499 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Mozambique DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 99%
M:F sex ratio at birth (2018) 1.03
Household survey: DTP3 coverage for male (2010) 76.20%
Household survey: DTP3 coverage for female (2010) 76.10%
Household survey: Last DTP3 survey (2010) 76%
% districts achieving > 80% DTP3 coverage (2017) 91%
% districts achieving < 50% DTP3 coverage (2017) 1%
MCV WHO/UNICEF estimates (2017) 85%

Breakdown of support

Non-vaccine support Vaccine support
12% 88%
$26,369,699 $198,790,148

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Mozambique

09 May 2018

IFPW STEP

IFPW and Gavi expand leadership training for a stronger supply chain

The partnership draws on private sector support to implement an innovative training and mentorship programme for supply chain managers in Gavi-supported countries.

02 May 2018

HPV vaccine's introduction into Zimbabwe's routine immunisation programme

Cervical cancer vaccine introduced in Zimbabwe

800,000 girls to be protected against disease following introduction of HPV vaccine.

21 December 2017

2017 letter

2017: responding to global challenges

Letter from Gavi's CEO, Dr Seth Berkley.

close icon

modal window here